Samantha Hullah, PhD

Executive Director, Biologics SME. at Syngene

Speaker

With a deep expertise in biologics and a passion for translating innovation into scalable solutions, Samantha Hullah has over 15 years of experience in the CDMO industry. She has led downstream recombinant protein purification programs as Technical Lead and managed viral gene therapy process development and manufacturing as Head of Site. In her current role she provides technical and CMC advice to Syngene’s potential biologics customers. She also serves as the technical liaison between front line sales and operations teams. Based in Cambridge, Massachusetts today, she hails from the North East of England and supports a global commercial team.

Syngene is a CRDMO with sites in India and the USA. The biologics division specialises in developing and manufacturing mammalian and microbially expressed recombinant proteins, offering end to end services from cell line development to drug product filling. To streamline outsourcing for our clients, Syngene provides ancillary services such as in house viral clearance testing and collaborates closely with its discovery division to translate candidates into medicines. Syngene also offers expertise in the discovery, development and manufacture of small molecules, oligonucleotides and ADCs.